Biochemistry, Genetics and Molecular Biology
Low-Density Lipoprotein
100%
Triglyceride
58%
Lipoprotein
54%
Apolipoprotein B
47%
Very Low-Density Lipoprotein
47%
Cholesterol Blood Level
42%
Hypercholesterolemia
42%
Metabolic Pathway
39%
Lipid
37%
Hypertriglyceridemia
37%
Bile Acid
35%
HDL-Cholesterol
29%
Dyslipidemia
29%
Insulin Resistance
28%
Familial Hypercholesterolemia
25%
Triacylglycerol Blood Level
22%
Cholesterol Level
21%
Lipoprotein Blood Level
20%
High-Density Lipoprotein
20%
High Density Lipoprotein Cholesterol Level
19%
Blood Pressure
17%
Blood Lipids
16%
Genetics
16%
Triacylglycerol Lipase
16%
Pancreatic Lipase
16%
Hepatic Lipase
16%
Low Density Lipoprotein Cholesterol Level
15%
Statin
15%
Secretion (Process)
15%
Blood Level
15%
Saturated Fatty Acid
15%
LDL Receptor
14%
Body Mass
14%
Prevalence
13%
Body Fat
13%
Glucose Blood Level
13%
Apolipoprotein
12%
Monounsaturated Fat
12%
Hyperglycemia
11%
Absorption
11%
Lovastatin
9%
Triacylglycerol Level
9%
Cholesterol Metabolism
9%
Lipid Metabolism
8%
Combined Hyperlipidemia
8%
Magnetism
8%
Adiponectin
8%
Polyunsaturated Fatty Acid
7%
Low-Density Lipoprotein Metabolism
7%
Body Weight
7%
Pharmacology, Toxicology and Pharmaceutical Science
Lipoprotein
73%
Low Density Lipoprotein
59%
Low Density Lipoprotein Cholesterol
55%
Metabolic Syndrome X
52%
Triacylglycerol
52%
Ischemic Heart Disease
46%
High Density Lipoprotein Cholesterol
43%
Dyslipidemia
39%
Hypercholesterolemia
39%
Mevinolin
36%
Statin (Protein)
28%
Very Low Density Lipoprotein
27%
Bile Acid
26%
Apolipoprotein B
25%
Hypertriglyceridemia
23%
Atherosclerosis
22%
Coronary Artery Atherosclerosis
22%
Non Insulin Dependent Diabetes Mellitus
21%
Hyperlipidemia
21%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
19%
Pharmacotherapy
18%
Cardiovascular Disease
18%
Atorvastatin
14%
Disease
13%
High Density Lipoprotein
13%
Gallstone
13%
Placebo
12%
Prevalence
12%
Familial Hypercholesterolemia
11%
C Reactive Protein
11%
Insulin Resistance
11%
Coronary Artery Disease
11%
Nicotinic Acid
11%
Diabetes Mellitus
11%
Chenodeoxycholic Acid
10%
Cardiovascular Risk
10%
Clinical Trial
9%
Biological Marker
9%
Obesity
9%
Apolipoprotein
8%
Colestipol
8%
Hypocholesterolemic Agent
8%
Very Low Density Lipoprotein Cholesterol
8%
Cholesterol Stone
7%
Fatty Acid
7%
Oxidoreductase
7%
Intermediate Density Lipoprotein
7%
Pancreatic Lipase
6%
Fenofibrate
6%
Clofibrate
6%
Keyphrases
Low-density Lipoprotein
52%
Cholesterol
42%
Metabolic Syndrome
32%
High-density Lipoprotein Cholesterol (HDL-C)
32%
Low-density Lipoprotein Cholesterol (LDL-C)
31%
Cholesterol Levels
26%
Coronary Artery Disease
24%
Apolipoprotein B (Apo B)
21%
Lovastatin
21%
Lipoproteins
20%
Risk Factors
20%
Hypercholesterolemia
19%
Atherosclerotic Cardiovascular Disease (ASCVD)
18%
Hypertriglyceridemia
17%
Obesity
16%
Statins
15%
Bile Acids
14%
Dyslipidemia
13%
Plasma Lipoproteins
12%
Metabolism
12%
Primary Prevention
12%
Low-density Lipoprotein Cholesterol Level
12%
Homozygous Familial Hypercholesterolemia (HoFH)
11%
Triglycerides
11%
High Risk
11%
Plasma Cholesterol
11%
Non-insulin-dependent Diabetes Mellitus (NIDDM)
11%
LDL Cholesterol
10%
Type 1 Diabetes Mellitus (T1DM)
9%
Type 2 Diabetes Mellitus (T2DM)
9%
Statin Therapy
9%
Mevinolin
9%
Insulin Resistance
9%
Lipoprotein Levels
9%
Plasma Triglycerides
9%
Carbohydrates
9%
Triglyceride Level
9%
Dallas Heart Study
9%
Coronary Artery Calcium
9%
Combined Hyperlipidemia
9%
Drug Therapy
8%
Colestipol
8%
National Cholesterol Education Program
8%
Hepatic Lipase
8%
Normolipidemic
7%
Plasma Lipids
7%
Clinical Trials
7%
Cholesterol Management
7%
Cholesterol-lowering Drugs
7%
Nicotinic Acid
7%
